FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2082908478> ?p ?o ?g. }

• W2082908478 endingPage "490" @default.
• W2082908478 startingPage "485" @default.
• W2082908478 abstract "INTRODUCTION: Toxoplasmosis is usually a benign infection, except in the event of ocular, central nervous system (CNS), or congenital disease and particularly when the patient is immunocompromised. Treatment consists of drugs that frequently cause adverse effects; thus, newer, more effective drugs are needed. In this study, the possible activity of artesunate, a drug successfully being used for the treatment of malaria, on Toxoplasma gondii growth in cell culture is evaluated and compared with the action of drugs that are already being used against this parasite. METHODS: LLC-MK2 cells were cultivated in RPMI medium, kept in disposable plastic bottles, and incubated at 36ºC with 5% CO2. Tachyzoites of the RH strain were used. The following drugs were tested: artesunate, cotrimoxazole, pentamidine, pyrimethamine, quinine, and trimethoprim. The effects of these drugs on tachyzoites and LLC-MK2 cells were analyzed using nonlinear regression analysis with Prism 3.0 software. RESULTS: Artesunate showed a mean tachyzoite inhibitory concentration (IC50) of 0.075µM and an LLC MK2 toxicity of 2.003µM. Pyrimethamine was effective at an IC50 of 0.482µM and a toxicity of 11.178µM. Trimethoprim alone was effective against the in vitro parasite. Cotrimoxazole also was effective against the parasite but at higher concentrations than those observed for artesunate and pyrimethamine. Pentamidine and quinine had no inhibitory effect over tachyzoites. CONCLUSIONS: Artesunate is proven in vitro to be a useful alternative for the treatment of toxoplasmosis, implying a subsequent in vivo effect and suggesting the mechanism of this drug against the parasite." @default.
• W2082908478 created "2016-06-24" @default.
• W2082908478 creator A5010534673 @default.
• W2082908478 creator A5043314101 @default.
• W2082908478 creator A5064835435 @default.
• W2082908478 creator A5070726513 @default.
• W2082908478 date "2012-08-01" @default.
• W2082908478 modified "2023-09-26" @default.
• W2082908478 title "In vitro action of antiparasitic drugs, especially artesunate, against Toxoplasma gondii" @default.
• W2082908478 cites W1580003617 @default.
• W2082908478 cites W1971496928 @default.
• W2082908478 cites W1997896230 @default.
• W2082908478 cites W2019145353 @default.
• W2082908478 cites W2022310297 @default.
• W2082908478 cites W2023941860 @default.
• W2082908478 cites W2079098038 @default.
• W2082908478 cites W2102976549 @default.
• W2082908478 cites W2119353752 @default.
• W2082908478 cites W2121269154 @default.
• W2082908478 cites W2123067954 @default.
• W2082908478 cites W2128459803 @default.
• W2082908478 cites W2144031245 @default.
• W2082908478 cites W2145891295 @default.
• W2082908478 cites W2151019491 @default.
• W2082908478 cites W2172073437 @default.
• W2082908478 cites W2279903097 @default.
• W2082908478 cites W2413811278 @default.
• W2082908478 cites W4211140781 @default.
• W2082908478 doi "https://doi.org/10.1590/s0037-86822012000400014" @default.
• W2082908478 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22930046" @default.
• W2082908478 hasPublicationYear "2012" @default.
• W2082908478 type Work @default.
• W2082908478 sameAs 2082908478 @default.
• W2082908478 citedByCount "18" @default.
• W2082908478 countsByYear W20829084782013 @default.
• W2082908478 countsByYear W20829084782014 @default.
• W2082908478 countsByYear W20829084782015 @default.
• W2082908478 countsByYear W20829084782016 @default.
• W2082908478 countsByYear W20829084782017 @default.
• W2082908478 countsByYear W20829084782018 @default.
• W2082908478 countsByYear W20829084782019 @default.
• W2082908478 countsByYear W20829084782021 @default.
• W2082908478 countsByYear W20829084782022 @default.
• W2082908478 crossrefType "journal-article" @default.
• W2082908478 hasAuthorship W2082908478A5010534673 @default.
• W2082908478 hasAuthorship W2082908478A5043314101 @default.
• W2082908478 hasAuthorship W2082908478A5064835435 @default.
• W2082908478 hasAuthorship W2082908478A5070726513 @default.
• W2082908478 hasBestOaLocation W20829084781 @default.
• W2082908478 hasConcept C126322002 @default.
• W2082908478 hasConcept C159047783 @default.
• W2082908478 hasConcept C159654299 @default.
• W2082908478 hasConcept C203014093 @default.
• W2082908478 hasConcept C2777035104 @default.
• W2082908478 hasConcept C2777425658 @default.
• W2082908478 hasConcept C2777530519 @default.
• W2082908478 hasConcept C2777617192 @default.
• W2082908478 hasConcept C2777914695 @default.
• W2082908478 hasConcept C2778048844 @default.
• W2082908478 hasConcept C2778059366 @default.
• W2082908478 hasConcept C2778062946 @default.
• W2082908478 hasConcept C2778128430 @default.
• W2082908478 hasConcept C2778371730 @default.
• W2082908478 hasConcept C2780035454 @default.
• W2082908478 hasConcept C2780728791 @default.
• W2082908478 hasConcept C29730261 @default.
• W2082908478 hasConcept C501593827 @default.
• W2082908478 hasConcept C71924100 @default.
• W2082908478 hasConcept C86803240 @default.
• W2082908478 hasConcept C89423630 @default.
• W2082908478 hasConcept C98274493 @default.
• W2082908478 hasConceptScore W2082908478C126322002 @default.
• W2082908478 hasConceptScore W2082908478C159047783 @default.
• W2082908478 hasConceptScore W2082908478C159654299 @default.
• W2082908478 hasConceptScore W2082908478C203014093 @default.
• W2082908478 hasConceptScore W2082908478C2777035104 @default.
• W2082908478 hasConceptScore W2082908478C2777425658 @default.
• W2082908478 hasConceptScore W2082908478C2777530519 @default.
• W2082908478 hasConceptScore W2082908478C2777617192 @default.
• W2082908478 hasConceptScore W2082908478C2777914695 @default.
• W2082908478 hasConceptScore W2082908478C2778048844 @default.
• W2082908478 hasConceptScore W2082908478C2778059366 @default.
• W2082908478 hasConceptScore W2082908478C2778062946 @default.
• W2082908478 hasConceptScore W2082908478C2778128430 @default.
• W2082908478 hasConceptScore W2082908478C2778371730 @default.
• W2082908478 hasConceptScore W2082908478C2780035454 @default.
• W2082908478 hasConceptScore W2082908478C2780728791 @default.
• W2082908478 hasConceptScore W2082908478C29730261 @default.
• W2082908478 hasConceptScore W2082908478C501593827 @default.
• W2082908478 hasConceptScore W2082908478C71924100 @default.
• W2082908478 hasConceptScore W2082908478C86803240 @default.
• W2082908478 hasConceptScore W2082908478C89423630 @default.
• W2082908478 hasConceptScore W2082908478C98274493 @default.
• W2082908478 hasIssue "4" @default.
• W2082908478 hasLocation W20829084781 @default.
• W2082908478 hasLocation W20829084782 @default.
• W2082908478 hasLocation W20829084783 @default.
• W2082908478 hasOpenAccess W2082908478 @default.

• next